{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:54:55Z","timestamp":1793775295304,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00467-022-05783-z","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T09:05:41Z","timestamp":1669799141000},"page":"2107-2116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3863-2743","authenticated-orcid":false,"given":"Shingo","family":"Ishimori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Matsunoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Kamiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"5783_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"5783_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, Gulati A, Kalaivani M, Mantan M, Dinda AK, Srivastava RN, Bagga A\u00a0(2012) Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr 49:881\u2013887","journal-title":"Indian Pediatr"},{"key":"5783_CR3","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO): The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines-application to the individual patient. Available at. https:\/\/kdigo.org\/guidelines\/gd\/. Accessed 1 January\u00a02021"},{"key":"5783_CR4","first-page":"402","volume":"58","author":"I Szajner-Milart","year":"2003","unstructured":"Szajner-Milart I, Zajaczkowska M, Zinkiewicz Z, Borzecka H, Majewski M\u00a0(2003) Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome. Ann univ Mariae Curie Sklodowska Med 58:402\u2013408","journal-title":"Ann univ Mariae Curie Sklodowska Med"},{"key":"5783_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1067\/mpd.2003.37","volume":"142","author":"SL Furth","year":"2003","unstructured":"Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA, Southwest Pediatric Nephrology Study Group\u00a0(2003) Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J Pediatr 142:145\u2013148","journal-title":"J Pediatr"},{"key":"5783_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","volume":"17","author":"H Alpay","year":"2002","unstructured":"Alpay H, Yildiz N, Onar A, Temizer H, Oz\u00e7ay S\u00a0(2002) Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 17:181\u2013183","journal-title":"Pediatr Nephrol"},{"key":"5783_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)14072-X","volume":"362","author":"AS Abeyagunawardena","year":"2003","unstructured":"Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS (2003) Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 362:449\u2013450","journal-title":"Lancet"},{"key":"5783_CR8","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.vaccine.2013.05.004","volume":"31","author":"N Yildiz","year":"2013","unstructured":"Yildiz N, Sever L, Kasap\u00e7opur \u00d6, \u00c7ullu F, Arisoy N, \u00c7aliskan S\u00a0(2013) Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety? Vaccine 31:3309\u20133312","journal-title":"Vaccine"},{"key":"5783_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.vaccine.2013.11.106","volume":"32","author":"CD Liakou","year":"2014","unstructured":"Liakou CD, Askiti V, Mitsioni A, Stefanidis CJ, Theodoridou MC, Spoulou VI\u00a0(2014) Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine 32:1394\u20131397","journal-title":"Vaccine"},{"key":"5783_CR10","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiello B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol 12:332\u2013345","journal-title":"C J Am Soc Nephrol"},{"key":"5783_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.ajkd.2010.04.011","volume":"56","author":"P Fernandes","year":"2010","unstructured":"Fernandes P, Jorge S, Lopes JA (2010) Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine. Am J Kidney Dis 56:185\u2013186","journal-title":"Am J Kidney Dis"},{"key":"5783_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10157-011-0562-6","volume":"16","author":"SR Kim","year":"2012","unstructured":"Kim SR, Lee SB, Kim IY, Lee DW, Rhee H, Seong EY, Song SH, Kwak IS\u00a0(2012) Relapse of minimal change disease following infection with the 2009 pandemic influenza (H1N1) virus. Clin Exp Nephrol 16:329\u2013332","journal-title":"Clin Exp Nephrol"},{"key":"5783_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10157-020-01930-8","volume":"24","author":"S Ishimori","year":"2020","unstructured":"Ishimori S, Kamei K, Ando T, Yoshikawa T, Kano Y, Nagata H, Saida K, Sato M, Ogura M, Ito S, Ishikura K\u00a0(2020) Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse. Clin Exp Nephrol 24:1069\u20131076","journal-title":"Clin Exp Nephrol"},{"key":"5783_CR14","doi-asserted-by":"publisher","first-page":"23305","DOI":"10.1038\/s41598-021-02644-x","volume":"11","author":"S Ishimori","year":"2021","unstructured":"Ishimori S, Ando T, Kikunaga K, Terano C, Sato M, Komaki F, Hamada R, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M, Ishikura K\u00a0(2021) Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and virus infection as assessed in a nationwide survey. Sci Rep 11:23305. https:\/\/doi.org\/10.1038\/s41598-021-02644-x","journal-title":"Sci Rep"},{"key":"5783_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2215\/CJN.01890221","volume":"16","author":"A Angeletti","year":"2021","unstructured":"Angeletti A, Bruschi M, Bianchin S, Bonato I, Montobbio C, Verrina E, Lugani F, Cravedi P, Ghiggeri GM\u00a0(2021) Vaccines and disease relapses in children with nephrotic syndrome. Clin J Am Soc Nephrol 16:937\u2013938","journal-title":"Clin J Am Soc Nephrol"},{"key":"5783_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10157-014-1030-x","volume":"19","author":"K Ishikura","year":"2015","unstructured":"Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Kaku Y, Iijima K, Japanese Society for Pediatric Nephrology, Japanese Society for Pediatric Nephrology\u00a0(2015) Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol 19:6\u201333","journal-title":"Clin Exp Nephrol"},{"key":"5783_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10157-014-1031-9","volume":"19","author":"Y Kaku","year":"2015","unstructured":"Kaku Y, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, Kondo S, Ikezumi Y, Tanaka S, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, Saito H, Fujinaga S, Hamasaki Y, Chikamoto H, Ishikura K, Iijima K, Japanese Society for Pediatric Nephrology\u00a0(2015) Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy. Clin Exp Nephrol 19:34\u201353","journal-title":"Clin Exp Nephrol"},{"key":"5783_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","volume":"26","author":"M van Husen","year":"2011","unstructured":"van Husen M, Kemper MJ (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol 26:881\u2013892","journal-title":"Pediatr Nephrol"},{"key":"5783_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K, Japanese Study Group of Kidney Disease in Children\u00a0(2015) A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87:225\u2013232","journal-title":"Kidney Int"},{"key":"5783_CR20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/j.ajkd.2021.06.008","volume":"78","author":"S Leclerc","year":"2021","unstructured":"Leclerc S, Royal V, Lamarche C, Laurin LP (2021) Minimal change disease with severe acute kidney injury following the Oxford-AstraZeneca COVID-19 vaccine: a case report. Am J Kidney Dis 78:607\u2013610","journal-title":"Am J Kidney Dis"},{"key":"5783_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.ajkd.2021.03.010","volume":"78","author":"L Lebedev","year":"2021","unstructured":"Lebedev L, Sapojnikov M, Wechsler A, Varadi-Levi R, Zamir D, Tobar A, Levin-Iaina N, Fytlovich S, Yagil Y\u00a0(2021) Minimal change following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78:142\u2013145","journal-title":"Am J Kidney Dis"},{"key":"5783_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2369-10-21","volume":"10","author":"C Clajus","year":"2009","unstructured":"Clajus C, Spiegel J, Br\u00f6cker V, Chatzikyrkou C, Kielstein JT\u00a0(2009) Minimal change nephrotic syndrome in an 82 year old patient following a tetanus-diphteria-poliomyelitis-vaccination. BMC Nephrol 10:21","journal-title":"BMC Nephrol"},{"key":"5783_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ajem.2021.05.054","volume":"49","author":"B Long","year":"2021","unstructured":"Long B, Bridwell R, Gottlieb M (2021) Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Am J Emerg Med 49:58\u201361","journal-title":"Am J Emerg Med"},{"key":"5783_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"SGO Johansson","year":"2004","unstructured":"Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Martell JAO, Platts-Mills TAE, Ring J, Thien F, Van Cauwenberge P, Williams HC\u00a0(2004) Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113:832\u2013836","journal-title":"J Allergy Clin Immunol"},{"key":"5783_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0022-3476(86)80876-9","volume":"108","author":"NE MacDonald","year":"1986","unstructured":"MacDonald NE, Wolfish N, McLaine P, Phipps P, Rossier E\u00a0(1986) Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 108:378\u2013382","journal-title":"J Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05783-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05783-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05783-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:11:14Z","timestamp":1744207874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05783-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["5783"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05783-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards set by the Ethics Board at Kakogawa Central City Hospital in which the study was conducted (approval number 29\u201312) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Before enrollment, written informed consent was obtained from all patients and their parents for this study in accordance with guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"K.K. has received research funding from the Terumo Foundation for Life Sciences and Arts, Public Foundation of Vaccination Research Center, and Taiju Life Social Welfare Foundation; donations from Chugai Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., Teijin Pharma Ltd. Shionogi Co. Ltd., and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Tanabe Mitsubishi Pharma, Baxter Ltd., and Zenyaku Kogyo Co. Ltd. K. Ii. reports consultancy agreements with Zenyaku Kogyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., JCR Pharmaceuticals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Sanofi K.K.; research funding from Zenyaku Kogyo Co. Ltd., Astellas Pharma Inc., Air Water Medical Inc., Otsuka Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., Eisai Co. Ltd., Shionogi Co. Ltd., JCR Pharmaceuticals Co. Ltd. and Nihon Pharmaceutical Co. Ltd.; honoraria from Chugai Pharmaceutical Co. Ltd., Zenyaku Kogyo Co. Ltd., Kyowa Kirin Co. Ltd., Integrated Development Associates Co. Ltd., Astellas Pharma Inc. and Shionogi Co. Ltd.; a patent application on the development of antisense nucleotides for exon skipping therapy in Alport syndrome with Daiichi Sankyo Co. Ltd.; scientific advisor or membership as a member of editorial board of Pediatric Nephrology and Clinical Journal of the American Society of Nephrology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}